Form 8-K - Current report:
SEC Accession No. 0000950170-21-000388
Filing Date
2021-06-25
Accepted
2021-06-25 09:00:26
Documents
12
Period of Report
2021-06-24
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K rare-20210624.htm   iXBRL 8-K 57971
  Complete submission text file 0000950170-21-000388.txt   172114

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rare-20210624.xsd EX-101.SCH 2447
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rare-20210624_lab.xml EX-101.LAB 12936
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rare-20210624_pre.xml EX-101.PRE 9595
5 EXTRACTED XBRL INSTANCE DOCUMENT rare-20210624_htm.xml XML 4522
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)

EIN.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36276 | Film No.: 211044843
SIC: 2834 Pharmaceutical Preparations